Fig 1. The prevalence of multidrug-resistant tuberculosis (MDR-TB) in most European countries is higher among previously treated patients than among newly diagnosed patients.

The data on the percentage of newly diagnosed and previously treated patients with MDR-TB where taken from reference [35] for 2009 and from reference [36] for 2010. Countries with incomplete data were omitted.